share_log

JP Morgan Downgrades Metagenomi to Neutral, Lowers Price Target to $6

Benzinga ·  May 2 08:32

JP Morgan analyst Brian Cheng downgrades Metagenomi (NASDAQ:MGX) from Overweight to Neutral and lowers the price target from $16 to $6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment